ArticleClinical immunology (Orlando, Fla.)2022

IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient.

John D Mountz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.